Diabetic neuropathy is a serious complication of diabetes that occurs when persistently high blood sugar levels damage nerves throughout the body. While many people with diabetes will eventually face this challenge, there are ways to manage symptoms, slow progression, and maintain quality of life through both established medical treatments and emerging therapies being tested in clinical trials.

How Treatment Helps You Live Better with Nerve Damage

When you have diabetic neuropathy, the main goals of treatment focus on several important areas. First and foremost, doctors aim to slow down or prevent further nerve damage from occurring. This is crucial because once nerves are damaged, reversing that damage completely is extremely difficult. Second, treatment works to relieve the pain, tingling, numbness, and other uncomfortable symptoms that can seriously affect your daily life and sleep. Third, managing complications that arise from neuropathy—such as foot ulcers, digestive problems, or blood pressure issues—becomes essential. Finally, improving your overall function and helping you maintain independence in daily activities is a key priority.^[9]

The treatment approach depends heavily on which type of neuropathy you have and how severely it affects you. Peripheral neuropathy, which affects the feet and legs most commonly, requires different management than autonomic neuropathy, which impacts internal organs. Your age, other health conditions, and personal treatment goals all play important roles in determining the best path forward.^[1][4]

There are standard treatments that have been approved by medical societies and regulatory agencies for many years. At the same time, researchers continue exploring new therapies in clinical trials, offering hope for better pain control and potentially ways to protect or even repair damaged nerves. Understanding both options helps you make informed decisions about your care.^[12]

Standard Treatments: What Doctors Prescribe Today

The foundation of treating diabetic neuropathy starts with controlling blood sugar levels. Keeping your blood glucose—the amount of sugar in your blood—within your target range is absolutely critical. Studies have shown that people with type 1 diabetes who maintain excellent blood sugar control can reduce their risk of developing neuropathy by up to 60%. Even if you already have nerve damage, tightening your blood sugar control may prevent it from worsening and might even improve some symptoms over time.^[5][9]

When it comes to managing pain from neuropathy, common painkillers like paracetamol or ibuprofen often don’t work well because nerve pain is different from other types of pain. Instead, doctors use several specific types of medications that have proven effective in clinical studies.^[11]

Pregabalin and gabapentin belong to a group of medicines originally developed to treat epilepsy. They work by calming down overactive nerve signals that cause pain. Pregabalin, sold under the brand name Lyrica, has been extensively studied and approved specifically for diabetic nerve pain. Gabapentin, known as Neurontin, is also widely prescribed and has similar effects. Both medications need to be started at low doses and gradually increased to find the right balance between pain relief and side effects. Common side effects include drowsiness, dizziness, and sometimes swelling in the legs.^[11][12]

Duloxetine, marketed as Cymbalta, is another FDA-approved medication for diabetic neuropathy. It belongs to a class called serotonin-norepinephrine reuptake inhibitors, or SNRIs, which were originally designed to treat depression. Duloxetine works by increasing certain chemicals in the brain and spinal cord that help reduce pain signals. You don’t need to be depressed for this medication to help with nerve pain. Side effects may include nausea, dry mouth, sleepiness, or constipation.^[11][12]

Amitriptyline is an older antidepressant medication that has been used for decades to treat nerve pain. It affects chemical messengers in the brain that influence pain perception. While very effective for many people, it tends to cause more side effects than newer medications, especially in older adults. These can include drowsiness, dry mouth, constipation, blurred vision, and difficulty urinating. Because of these concerns, it’s often not the first choice for elderly patients. However, for younger adults who can tolerate it, amitriptyline can provide excellent pain relief.^[11]

Other antidepressants in the SNRI class include venlafaxine and desvenlafaxine (Pristiq). While not FDA-approved specifically for diabetic neuropathy, they have shown effectiveness in clinical studies and are considered second-line options when first-line treatments don’t provide adequate relief.^[11]

Tramadol and extended-release tapentadol (Nucynta ER) are opioid-like medications that can be used for severe nerve pain. Tapentadol received FDA approval for diabetic peripheral neuropathy in 2012. These medications work on opioid receptors in the brain and spinal cord to reduce pain perception. However, because they carry risks of dependence and addiction, they are typically reserved for situations where other medications haven’t worked. Doctors usually prescribe them for short periods or for breakthrough pain that occurs despite other treatments. Side effects include nausea, constipation, dizziness, and drowsiness.^[11][12]

Topical treatments applied directly to the skin can help some people, especially when pain affects specific areas. Capsaicin cream contains the substance that makes chili peppers hot. It works by reducing a chemical called substance P that nerves use to send pain signals. When first applied, it may cause burning or stinging, but this typically lessens with continued use. The cream needs to be applied three to four times daily to the painful area. A prescription version called QUTENZA delivers a higher concentration and must be applied by healthcare professionals in a clinic setting.^[12][21]

Lidocaine patches are another topical option. Lidocaine is a local anesthetic that numbs the area where it’s applied. The patches can be worn for up to 12 hours a day on the most painful spots. They may cause skin irritation but generally have fewer body-wide side effects than oral medications.^[12]

Treatment typically continues long-term, as diabetic neuropathy is a chronic condition. Your doctor will likely start you on one medication at a low dose, then gradually increase it over several weeks while monitoring your response and any side effects. If one medication doesn’t provide enough relief, your doctor might add a second medication from a different class, as combining medications with different mechanisms can sometimes work better than using just one.^[9]

Beyond medications for pain, treating other symptoms matters too. If you have digestive problems from autonomic neuropathy, you might need medications to help your stomach empty properly or to control nausea. Bladder problems may require specific medications or techniques. Sexual dysfunction in men might be treated with medications similar to those used for erectile dysfunction. Blood pressure medications can help if you experience dizziness from autonomic neuropathy affecting your cardiovascular system.^[4][10]

Physical therapy plays an important role for many people with diabetic neuropathy. If you have muscle weakness, a physical therapist can teach you exercises to improve strength and balance. This helps reduce your risk of falls and maintains your ability to walk and perform daily activities. Some people benefit from wearing special shoes or using devices like ankle braces to support weak muscles.^[9]

Taking excellent care of your feet is absolutely essential when you have peripheral neuropathy. Because you may not feel pain from injuries, cuts, or blisters, you need to check your feet daily for any problems. Washing your feet every day, drying them carefully (especially between the toes), and applying moisturizer helps prevent skin cracks that could become infected. Always wear properly fitting shoes and avoid going barefoot. See a foot specialist if you notice any sores, color changes, or other concerns.^[7][18]

Innovative Therapies Being Tested in Clinical Trials

While current treatments help many people manage symptoms, they don’t reverse nerve damage or work equally well for everyone. This is why researchers worldwide are investigating new approaches in clinical trials. These studies test whether experimental treatments are safe and whether they can provide better pain relief or actually protect and repair damaged nerves.^[12]

Clinical trials typically progress through three main phases. Phase I trials involve small groups of people and focus primarily on safety—determining what dose can be given safely and what side effects occur. Phase II trials include more participants and begin to assess whether the treatment actually works to improve symptoms or slow disease progression. Phase III trials are large studies that compare the new treatment directly against current standard treatments to see if it works better, as well as, or differently.^[12]

Alpha-lipoic acid is an antioxidant that has been extensively studied for diabetic neuropathy, particularly in Europe. The theory behind its use is that high blood sugar causes oxidative stress—a process where harmful molecules called free radicals damage cells, including nerve cells. Alpha-lipoic acid helps neutralize these free radicals. Studies have tested both oral and intravenous forms. Some clinical trials have shown improvements in pain, burning, and tingling sensations, as well as slight improvements in nerve function tests. However, results have been mixed, and it hasn’t received FDA approval in the United States. More research is needed to determine optimal dosing and which patients might benefit most.^[12]

Benfotiamine is a fat-soluble form of vitamin B1 (thiamine) that may help prevent vascular damage in diabetes. The idea is that high blood sugar causes glucose to be processed through harmful pathways in cells. Benfotiamine may block these pathways, potentially protecting nerves. Several studies have investigated its effects, with some showing modest improvements in symptoms. However, like alpha-lipoic acid, evidence remains inconclusive, and it’s not approved as a standard treatment.^[12]

Aldose reductase inhibitors represent another approach based on understanding how high blood sugar damages nerves. When blood sugar is high, glucose can be converted through a pathway called the polyol pathway, which produces substances that may be toxic to nerves. Aldose reductase inhibitors block a key enzyme in this pathway. Despite promising theory, multiple clinical trials of various aldose reductase inhibitors have been disappointing, with most failing to show clear benefits or having unacceptable side effects.^[12]

Nav 1.7 antagonists are experimental drugs targeting a specific sodium channel called Nav 1.7, which is involved in transmitting pain signals. People born with genetic mutations that disable Nav 1.7 cannot feel pain, which led researchers to investigate whether blocking this channel with drugs could relieve neuropathic pain. Several pharmaceutical companies are developing Nav 1.7 inhibitors and testing them in clinical trials for various painful conditions, including diabetic neuropathy. Early phase trials are evaluating safety and whether these drugs can reduce pain without causing the numbness and muscle weakness seen with older sodium channel blockers.^[12]

N-type calcium channel blockers work by preventing calcium from entering nerve terminals, which reduces the release of pain-signaling chemicals. An injectable medication called ziconotide, which blocks N-type calcium channels, is already approved for severe chronic pain but requires delivery directly into the spinal fluid through a pump, limiting its use. Researchers are working on developing N-type calcium channel blockers that can be taken as pills and might be better tolerated.^[12]

Nerve growth factor (NGF) antibodies represent a different approach. NGF is a protein that helps nerves survive and function, but in certain pain conditions, too much NGF signaling may contribute to pain. Antibodies that block NGF have been studied primarily for arthritis pain, with some trials also exploring their use in neuropathic pain. However, safety concerns have emerged in some studies, including rare cases of rapidly progressing joint damage, so research continues cautiously.^[12]

Angiotensin II type 2 receptor antagonists are being investigated based on the idea that this receptor system may play a role in nerve inflammation and pain. Blocking this receptor might reduce inflammatory processes that contribute to neuropathy. These drugs are in relatively early stages of clinical testing.^[12]

Spinal cord stimulators represent a non-drug approach for severe, intractable pain that doesn’t respond to medications. These devices are surgically implanted and deliver mild electrical pulses to the spinal cord, which can interrupt or modify pain signals before they reach the brain. Spinal cord stimulation has been used for various chronic pain conditions for years, and newer technology allows for more targeted stimulation patterns. Clinical trials are evaluating their effectiveness specifically for diabetic neuropathy pain. The procedure requires careful patient selection and involves both a trial period and permanent implantation if successful.^[21]

Transcutaneous electrical nerve stimulation (TENS) is a simpler, non-invasive form of electrical stimulation. Small electrodes are placed on the skin, and a device delivers gentle electrical pulses. The theory is that this can help block pain signals or stimulate the body’s natural pain-relieving mechanisms. Some studies suggest TENS may provide relief for some people with diabetic neuropathy, though results vary considerably between individuals. It can be tried at any point during treatment without interfering with medications.^[11]

Clinical trials for diabetic neuropathy are conducted in various locations worldwide, including the United States, Europe, and other regions. To participate in a trial, patients typically need to meet specific eligibility criteria, which might include having a certain type and severity of neuropathy, being within a particular age range, and not having certain other medical conditions. Trial participation involves regular monitoring and may require travel to research centers. Your doctor can help you understand whether participating in a clinical trial might be appropriate for you and can help identify relevant studies.^[6]

Some alternative approaches have also been studied, though evidence for their effectiveness remains limited. Acupuncture, the traditional Chinese practice of inserting thin needles at specific points on the body, has been investigated for neuropathic pain with mixed results. Some people report benefit, but high-quality clinical trials haven’t consistently demonstrated effectiveness. Acetyl-L-carnitine is an amino acid derivative that some studies suggest might have nerve-protective effects, but evidence is insufficient to recommend it routinely. Similarly, evening primrose oil, which contains gamma-linolenic acid, has been studied based on theories about how it might help nerve function, but clinical trial results haven’t been convincing enough to establish it as a standard treatment.^[11]

Most common treatment methods

• Blood sugar control
  • The most critical foundation of treatment, involving careful management of glucose levels through diet, physical activity, and medications when necessary
  • Can reduce the risk of developing neuropathy by up to 60% in people with type 1 diabetes
  • May slow progression and even improve some symptoms in people who already have nerve damage
• Anticonvulsant medications
  • Pregabalin (Lyrica) – FDA-approved specifically for diabetic neuropathy, works by calming overactive nerve signals
  • Gabapentin (Neurontin) – Similar mechanism to pregabalin, widely prescribed as first-line therapy
  • Started at low doses and gradually increased to balance pain relief with side effects like drowsiness and dizziness
• Antidepressant medications
  • Duloxetine (Cymbalta) – FDA-approved SNRI that increases pain-reducing chemicals in the brain and spinal cord
  • Amitriptyline – Older tricyclic antidepressant, very effective but can cause more side effects, especially in elderly patients
  • Venlafaxine and desvenlafaxine (Pristiq) – Other SNRIs used as second-line options
  • Work for nerve pain even in people who are not depressed
• Opioid-like pain medications
  • Tramadol – Used for more severe pain that doesn’t respond to other treatments
  • Tapentadol extended-release (Nucynta ER) – FDA-approved for diabetic neuropathy in 2012
  • Reserved for situations where other medications haven’t provided adequate relief due to risk of dependence
  • Typically prescribed for short periods or for breakthrough pain
• Topical treatments
  • Capsaicin cream – Applied 3-4 times daily, reduces substance P that transmits pain signals
  • QUTENZA – Prescription high-concentration capsaicin patch applied by healthcare providers in clinic
  • Lidocaine 5% patches – Provide local numbing effect, worn up to 12 hours daily
  • Useful for localized pain areas with fewer body-wide side effects than oral medications
• Experimental pathogenetic treatments (in clinical trials)
  • Alpha-lipoic acid – Antioxidant tested in oral and intravenous forms to combat oxidative stress
  • Benfotiamine – Fat-soluble vitamin B1 that may protect against vascular damage
  • Aldose reductase inhibitors – Block harmful glucose metabolism pathways, though trials have been disappointing
• Novel pain pathway modulators (in clinical trials)
  • Nav 1.7 antagonists – Target specific sodium channels involved in pain transmission
  • N-type calcium channel blockers – Prevent release of pain-signaling chemicals from nerve terminals
  • Nerve growth factor (NGF) antibodies – Block excessive NGF signaling that may contribute to pain
  • Angiotensin II type 2 receptor antagonists – May reduce inflammatory processes contributing to neuropathy
• Electrical stimulation therapies
  • Spinal cord stimulators – Implanted devices delivering electrical pulses to interrupt pain signals, for severe intractable pain
  • Transcutaneous electrical nerve stimulation (TENS) – Non-invasive surface electrodes delivering gentle electrical pulses
  • Can be added to treatment at any point without interfering with medications
• Physical therapy and supportive care
  • Exercise programs to improve muscle strength and balance, reducing fall risk
  • Ankle braces or special shoes to support weak muscles
  • Daily foot checks and meticulous foot care to prevent injuries and infections
  • Treatment of other symptoms like digestive, bladder, or sexual dysfunction as needed